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This work evaluated the levels of 5-aminolevulinic acid (ALA) in
the liver of rats exposed to different doses of HCB (25,50, and
100 mg/kg b.w. for 4 weeks) and correlated them with lipid
peroxidation parameters. Levels of ALA were determined by high-
pressure liquid chromatography after derivatization with
acetylacetone and formaldehyde, followed by fluorescence
detection. The methodology was carefully validated, nonetheless
hepatic levels of ALA in all animals treated or not were below the
detection limit of the method (2.27mg of ALA/g liver). On the other
hand, lipid peroxidation, evaluated as thiobarbituric acid reactants
production and chemiluminescence was found significantly
increased in the livers of all treated rats, in comparison with control
values (p<0.05). These results suggest that the hepatic oxidative
stress observed in animals following HCB treatment may not
necessarily be associated with increased levels of ALA in the liver.
Another possibility is that increased levels of ALA in the liver, even
below the detection limit of the method are sufficient to induce
hepatic oxidative stress.
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INTRODUCTION
Hexachlorobenzene (HCB) has been used in the past as
a fungicide for crop protection. Nowadays, it can be released
in the environment as a by-product of the chemical industry
and it may be present as impurity in the formulation of several
widely used pesticides (Jacoff et al., 1986).
Between 1955 and 1959 many people in
southeastern Turkey developed chronic porphyria after
consuming wheat that had been treated with HCB
(Schmid, 1960). HCB was shown to be hepatotoxic;
effects in the liver range from hepatocellular enlargement
to severe disturbance of the haem synthesis, resulting in
accumulation of porphyrins in the liver and their massive
excretion in the urine, as consequence of the inhibition of
hepatic uroporphyrinogen-decarboxylase activity (URO-
D) (Elder et al., 1976; Börge et al., 1979).
Reactive oxygen species (ROS) have been proposed
to play an important role in the pathogenesis of the
porphyria caused by polyhalogenated aromatic
hydrocarbons, such as HCB (Ferioli et al., 1984; Almeida
et al., 1997; Billi de Catabbi et al., 1997). Several authors
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have shown an increase of lipid peroxidation in the liver of
rats treated with different doses of HCB. According to Billi
de Catabbi et al. (1997), the increase in lipid peroxidation
found in the liver of rats treated with 1g/kg b.w. of HCB
reflects rises in ROS levels. Almeida et al. (1997)
postulated this higher lipid peroxidation could be a
consequence of increased levels of superoxide anion
produced by cytochrome P450 (Urquhart, Elder, 1987;
Visser et al., 1989; Almeida et al., 1997). Additionally, ROS
could also play some role in the inhibitory process of URO-
D, by formation of an URO-D inhibitor (De Matteis, 1988).
Uroporphyrinogen-decarboxylase is the key enzyme
of the heme metabolic pathway, which is blocked in cases of
porphyria, not only in humans but also in the experimental
HCB-induced model. This blockage impairs the regulation of
the heme pathway as observed in lead intoxication (Elder et
al., 1976; Hindmarsh, 1986) when ALA-dehydratase is
inhibited, leading to the increase of ALA excretion in urine
(Wainstok De Calmanovici et al., 1986).
ALA has been proposed as an endogenous
prooxidant in these pathological conditions (Bechara et
al., 1996). Some authors reported the involvement of ROS
produced during autooxidation of enolic ALA in rat liver
mitochondria as an explanation to the pathophysiology of
acute intermittent porphyria (Hermes-Lima et al., 1991;
Monteiro et al., 1986; Vercesi et al., 1994). This work
sought to evaluate lipid peroxidation parameters in the
liver of rats exposed to different doses of HCB and their
correlation with the levels of ALA, considering this
molecule as a potent prooxidant with capacity to induce
oxidative stress.
MATERIAL AND METHODS
Animals and treatment
Male Wistar rats weighing 180-200 g were fed rat
chow (Purina, São Paulo, Brasil) ad libitum. HCB
dissolved in corn oil by sonication, was administered by
gavage (25, 50 and 100 mg/kg body wt.) 5 days a week for
4 weeks.
Control animals received isovolumetric amount of
corn oil (Mazola®). Animals were euthanized 24 hours
after the last dose by cervical dislocation.
5-aminolevulinic acid (ALA) determination by HPLC
Chemicals
5-Aminolevulinic acid hydrochloride (ALA) and N
-[2-hydroxyethyl]piperazine-N’ -[2-ethanesulfonic acid]
(HEPES) were purchased from Sigma (St. Louis, MO,
USA), formaldehyde, acetylacetone, methanol, 2-
mercaptoethanol and trichloroacetic acid were bought
from Merck (Darmstadt, Germany). The water used was
bidistilled and subsequently deionized.
Chromatographic conditions
The HPLC system consisted of a Model 510 Waters
pump coupled with a 1046 A Hewlett Packard
fluorescence detector and a SP4600 Data Jet Thermo
Separation integrator. The analytical conditions were as
follow: mobile phase, methanol-water (500:500, V:V);
analytical column, Supelcosil LC-18 Supecol (150 x 4.6
mm I.D., 5 mm particle diameter); flow-rate, 0.5 mL/min;
and injection volume, 20mL. The excitation and emission
wavelengths were set at 370 and 460 nm, respectively.
Standard solution
Stock standard solution of ALA was prepared by
dissolving 5 mg of 5-aminolevunilic acid in 50 mL of
deionized water and storing at 4 oC. This solution was
diluted to give appropriate concentrations of ALA.
Sample Collection
Liver (1g) non-perfused was homogenized (1:3 w:v)
in 10 mM N-[2-hydroxyethyl]piperazine-N’-[2-
ethanesulfonic acid] buffer pH 7.0 with a Teflon pestle in
a tight-fitting glass vessel and centrifuged for 5 min at
1000 x g at 4 oC. The pellet was discarded and the
supernatant was used for ALA determination.
ALA determination
A modification of the method described by
Okayama et al. (1990) was employed, replacing 2-
iodoacetamide by 2-mercaptoethanol to prevent thiol
formation.
Liver homogenates supernatant (250 mL), as
according described above, was added with 0.06 M 2-
mercaptoethanol (15 mL) and, after two minutes,
trichloroacetic acid 35% (60 mL). The mixture was
centrifuged at 1600 x g for 10 min, and the supernatant
(25 mL) was mixed with acetylacetone (100 mL), acetic
acid (625 mL) and formaldehyde solution 10% (250 mL).
The mixture was mixed in vortex, heated at 100 oC in a
multiblock heater for 10 min, cooled in an ice-cold water
bath to stop the derivatization reaction in a glass to the
dark conditions, and filtered through a 0.22 mm filter. The
filtrate (20 mL) was injected into the HPLC system.
Liver lipid peroxidation parameters
Sample preparation
Animals were euthanized by cervical dislocation.
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After opening the peritoneal cavity was done the excision
of a sample for the ALA determination, the liver was
perfused with cold 0.9% NaCl by portal vein, it was
removed, weighed and homogenized (1:3 w/v) in 140 mM
NaCl 40 mM Phosphate buffer pH 7.4 with a Teflon pestle
in a tight-fitting glass vessel and centrifuged for 20 min at
1000 x g at 4 oC. The supernatant was used for lipid
peroxidation evaluation as thiobarbituric acid reactants
(TBARs) and chemiluminescence (CL).
Thiobarbituric acid reactants (TBARs) measurement
The supernatant of liver homogenates was incubated
at 37 oC in a shaker water bath, diluted (1:3 v/v) in 0.1 M
potassium phosphate buffer pH 7.0. After a 2 hour
incubation, samples were precipitated with 5% TCA and
TBARs determined in the supernatant according to
Junqueira et al. (1986).
Chemiluminescence (CL) emission
The supernatant of liver homogenates was diluted
(1:8 v/v) in 140 mM NaCl 40 mM phosphate buffer pH 7.4
and incubated for 30 min at 37 oC in a shaker bath.
Chemiluminescence of the incubated liver homogenates
(3 mL) was measured in a Packard 1700R liquid
scintillation analyzer using the single photon monitor
mode at 25 oC. The values were expressed as cpm per
gram of tissue (Boveris et al., 1983).
Protein determination
Protein concentration was estimated employing the
biuret reagents (Layne, 1957).
Statistics
Mean values were compared by ANOVA followed
by Tukey’s test. Differences were considered statistically
significant when p values were less than 0.05.
RESULTS
ALA analysis
Validation of method
Typical chromatograms of the ALA derivative (200
mg/ L ALA standard solution), a liver sample to which
ALA has been added to prepare 200 mg/ L of ALA in the
homogenate and liver sample from rats treated with 100
mg of HCB/ kg body wt. are show in Figure 1.
FIGURE 1 - HPLC chromatogram of ALA with fluorescence detector. (A) Chromatogram of 5-aminolevulinic acid
(ALA) in standard solution (200 mg/ L, left); (B) liver homogenate + ALA (prepared at 200 mg/ L, middle); (C) liver
sample from rats treated with HCB (100 mg/ kg body wt, right). Arrow = peak of ALA derivative. Retention of time:
15 min (ALA). Chromatographic conditions in the text.
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The concentration of ALA in the standard solution
(12.5-200 mg/L) linearly correlated to the fluorescence
intensity given by peak areas (r = 0.997). The calibration
curve for standard ALA can be represented by the
equation y = -9921+1070.5x, and that of the ALA liver
homogenate spiked with authentic ALA, by the equation
y = -12591.2 + 1223x (r = 0.998).
The reproducibility of ALA quantification was tested
in the liver samples with addition of ALA standard solution.
The variation coefficients ranged from 2.4 to 8.9% for
interday assay and 7% and from 17.5% for intraday assay.
The recovery of ALA added to liver homogenate (12.5, 50
and 200 mg/L) was 100%. The detection limit was 6.25 mg/L
or 0.74 µmol/20 mL of ALA.
ALA concentration in liver homogenate of both
control and HCB-treated (25, 50 and 100 mg/kg body wt)
were under the detection limit of the method (2.27 mg of
ALA/g liver).
Lipid peroxidation parameters in the liver of control
and HCB-treated rats
All animals treated with HCB showed increased
levels of TBARs and CL, as compared to control animals
(Table I).
DISCUSSION
In order to investigate the role of ALA in HCB-
induced liver oxidative stress, we validated the method
proposed by Okayama et al.  (1990) for ALA
determination in the hepatic tissue of rats. The detection
limit obtained was 0.74 µmol/ injection, or 2.27 µg/g of
liver, and the high recovery percentage (100%) shows that
ALA was not lost during the extraction procedure.
The validated method was subsequently employed
to determine ALA concentration in hepatic tissue of non-
treated and HCB-treated animals (25, 50 and 100 mg of
HCB/ kg b.w.). The results indicated levels of ALA lower
than 2.27 mg/g of liver, below the detection limit of the
method. According to McGillion et al.  (1974),
quantification of ALA in hepatic tissue of control animals
by isotopic methods resulted in 0.06 mg/g of liver. This
value is much below our detection limit of ALA and could
explain why ALA was not detected in the controls. The
fast elimination kinetics of ALA could be another
determinant. According to McGillion et al. (1974), ALA
could not be found in hepatic tissue of rats after 24 hours
of an intraperitoneal injection. Considering that the
animals were sacrificed after 24 hours of exposure to
HCB, we decided to further assess this possibility. Rats
were exposed to a high concentration of HCB (1 g/ kg
b.w.) for 3 days, enough time to induce hepatic lipid
peroxidation, as shown by Almeida and Barros (1994).
Even though animals were sacrificed after 30 minutes of
the last the administration of HCB, ALA levels in the liver
remained below the detection limit (results not shown).
Almeida et al. (1997) demonstrated that superoxide
anion production by the endoplasmic reticulum is
increased in rats treated with daily doses of 25 mg of HCB/
kg b.w. for 30 consecutive days. These increased levels of
superoxide anion could lead to the production of hydrogen
peroxide by Fenton reaction. According to De Matteis et
al. (1988), H2O2 can be responsible for the oxidation of
uroporphyrinogen, with the production of a sufficiently
stable oxidative derivative, which in turn could act as
inhibitor of URO-D.
Although we did not demonstrate an increase of
ALA in the liver of HCB-treated animals, our results
TABLE I - Lipid peroxidation parameters liver of non-treated and HCB-treated rats
TBARS (nmol/mg of protein/120 min)
Control rats  1.49 ± 0.27 (8) *
25 mg of HCB/kg 2.85 ± 0.57 (8) *
50 mg of HCB/kg 2.55 ± 0.61 (6) *
100 mg of HCB/kg 2.85 ± 0.59 (8) *
Chemiluminescence (counts/min.106/mg of protein
Control rats 1.5 ± 0.7 (6) *
25 mg of HCB/kg 2.8 ± 1.2 (6) *
50 mg of HCB/kg 3.5 ± 1.6 (6) *
100 mg of HCB/kg 3.7 ± 1.6 (6) *
Values represent the means ± SD. The number in parenthesis represents the number of animals per group
(*) Significantly different from control rats (p< 0.05)
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indicate an oxidative stress condition in the liver of these
animals (Table 1). Wainstok De Calmanovici et al. (1984)
demonstrated a decrease in the activity of hepatic URO-D
after 4 weeks in rats treated with 1 g of HCB/kg b.w.,
however, ALA levels were found increased only after 6
weeks of treatment. The results reinforce the hypothesis
that oxidative stress actually precedes ALA accumulation,
suggesting that, at an earlier time of exposure, other
factors, such as induction of cytochrome P450 (CYP450)
(Smith et al., 1990; Franklin et al., 1997, Almeida et al,
1997), followed by increase in superoxide anion
production (Almeida et al, 1997), may contribute to the
observed oxidative stress condition in the liver.
Nevertheless, one cannot exclude the possibility of ALA
participation as an inducer of hepatic oxidative stress at a
later phase of HCB exposure.
RESUMO
Ácido delta-aminolevulinico e estresse oxidativo
hepático na fase inicial da intoxicação experimental
por hexaclorobenzeno
Este trabalho avaliou os níveis de ácido delta-
aminolevulínico (ALA) em fígado de ratos expostos a di-
ferentes doses de hexaclorobenzeno (HCB) (25, 50 e
100 mg/kg de peso corpóreo) durante 4 semanas e
correlacionou com os parâmetros de peroxidação
lipídica. Os níveis de ALA foram determinados por
cromatografia líquida de alta eficiência após
derivatização com acetilacetona e formaldeído, seguida
de detecção de fluorescência. A metodologia foi cuidado-
samente validada, apesar disso, os níveis hepáticos de
ALA em todos os animais tratados ou não foram abaixo do
limite de detecção do método (2,27 mg de ALA/ g de fíga-
do). Por outro lado, para a peroxidação lipídica, avalia-
da como produção de reagentes ao ácido tiobarbitúrico e
quimiluminescência, os resultados foram significativa-
mente elevados em todos os animais tratados em compa-
ração com os do grupo controle (p <0,05). Estes resulta-
dos sugerem que o estresse oxidativo hepático observado
nos animais após tratamento com HCB não deve necessa-
riamente estar associado com o aumento das concentra-
ções de ALA no fígado. Uma outra possibilidade seria o
aumento nos níveis de ALA no fígado, mesmo que abaixo
do limite de detecção do método, sendo suficiente para
induzir estresse oxidativo hepático.
UNITERMOS: Hexaclorobenzeno. Estresse oxidativo.
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